Suppression of the phytohemagglutinin response to lymphocytes is an independent prognosticator in patients with squamous cell carcinoma of the esophagus

Ann Thorac Surg. 2003 Jul;76(1):260-5. doi: 10.1016/s0003-4975(03)00165-6.

Abstract

Background: The preoperative immunological condition of patients with malignant tumors should be considered in determining the prognosis.

Methods: A lymphoblastic transformation test in which lymphocytes were stimulated with phytohemagglutinin (PHA) was performed for 155 patients with esophageal squamous cell carcinoma (SCC).

Results: Multivariate analysis demonstrated that a lower preoperative PHA response (p = 0.028), as well as the depth of the tumor (p = 0.011), lymph node metastasis (p = 0.0003), lymphatic permeation (p = 0.002), and the incidence of postoperative complication (p = 0.016) were independent factors associated with a poor prognosis for patients with SCC of the esophagus.

Conclusions: A suppressed PHA response is an additional significant prognosticator for SCC of the esophagus.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / therapy
  • Chemotherapy, Adjuvant
  • Cohort Studies
  • Combined Modality Therapy
  • Esophageal Neoplasms / pathology*
  • Esophageal Neoplasms / therapy
  • Esophagectomy / methods
  • Female
  • Humans
  • Lymphocytes / metabolism*
  • Lymphocytes / physiology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Odds Ratio
  • Phytohemagglutinins / analysis
  • Phytohemagglutinins / metabolism*
  • Predictive Value of Tests
  • Preoperative Care
  • Probability
  • Prognosis
  • Radiotherapy, Adjuvant
  • Regression Analysis
  • Risk Assessment
  • Sensitivity and Specificity
  • Survival Analysis

Substances

  • Biomarkers, Tumor
  • Phytohemagglutinins